bioRxiv Science⌕ Search

Biology subjects

Lu, H.

Publications and source records attributed to Lu, H..

At least 91 records · Page 5Linked to original sources

Efficient Cell Factory Design by Combining Meta-Heuristic Algorithm with Enzyme Constrained Metabolic Models

The rational design of high-performance microbial cell factories remains a central challenge in sustainable biomanufacturing due to the complexity of metabolic networks and the difficulty of predicting synergistic genetic interventions. Despite recent advances in strain design algorithms, predicting combinatorial targets remains computationally prohibitive due to the combinatorial explosion. Here, we present MetaStrain, a unified computational framework that integrates enzyme-constrained models (ecModels) with meta-heuristic algorithms to identify non-intuitive combinatorial gene targets for improving product yields. MetaStrain first performs pre-screening through a modified enforced objective flux scanning algorithm to reduce the dimensionality of candidate genes and annotate editing strategies. The subsequent search module employs flexible individual encodings compatible with diverse meta-heuristic algorithms and adopts a bottom-up phenotype evaluation strategy enabling efficient exploration of the combinatorial design space. Integrated redundancy analysis tools further identify single and fixed-size combinatorial strategies, facilitating direct experimental implementation. Computational simulation in Saccharomyces cerevisiae reveals significant enhancements in 2-phenylethanol and spermidine biosynthesis, while controlling target count and covering experimentally validated targets. Experimental validation in Escherichia coli further confirmed the algorithms predictive power, achieving up to a 61.25% increase in L-tryptophan titer of the five-target combination strain. Overall, MetaStrain achieves high computational efficiency, stable convergence, and broad adaptability across diverse metabolic targets. This study provides a powerful tool for metabolic engineering, bridging computational prediction and experimental realization, and highlighting the potential of meta-heuristic optimization in synthetic biology.

bioinformatics↗

Metformin Does Not Attenuate Angiotensin II-Induced Aortic Aneurysms in Low-Density Lipoprotein Receptor Deficient Mice

BackgroundMetformin, a biguanide antihyperglycemic agent, prevents angiotensin II (AngII)-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient (ApoE-/-) mice. Low-density lipoprotein receptor-deficient (LDLR-/-) mice are also widely used as a hypercholesterolemic model, which more closely mimics the lipoprotein profile of patients with hypercholesterolemia than ApoE-/- mice. In addition, LDLR-/- mice exhibit characteristics of glucose metabolism that are distinct from ApoE-/- mice. However, it remains unknown whether metformin suppresses AngII-induced aortic aneurysm formation in LDLR-/- mice. MethodsMale LDLR-/- mice at 9 weeks of age were administered either vehicle or metformin in drinking water and fed a Western diet. Subsequently, AngII was infused into mice for 4 weeks. Plasma metformin concentrations were measured by mass spectrometry. Maximal aortic diameters and areas were measured ex vivo. ResultsMass spectrometry analysis determined plasma metformin concentrations in mice administered the drug. Metformin administration resulted in lower body weight compared to the vehicle group, indicating effective metformin administration. However, ex vivo measurements demonstrated that metformin did not reduce aortic diameters in the suprarenal abdominal region. In addition, metformin failed to prevent AngII-induced ascending aortic dilatations. ConclusionMetformin did not attenuate AngII-induced aortic aneurysm formation in either the ascending or suprarenal abdominal region of LDLR-/- mice.

pathology↗

Metabolic modulation of intratumoral cholesterol with gut microbiota for the treatment of colorectal cancer

Excess cholesterol is positively correlated with colorectal cancer (CRC). Current therapeutic strategies for modulating cholesterol levels in CRC are limited and often come with complications. Here, we demonstrated that microbiome shunting of intestinal cholesterol to anticancer metabolites is a safe and applicable therapeutic approach for CRC. By screening major microbial metabolic products of cholesterol, we found that 4-cholesten-3-one (4-C-3) was selectively depleted in fecal samples and tumor tissues of patients with CRC. 4-C-3 exhibits strong antitumor effects on human CRC cell lines, patient-derived organoids, and patient-derived xenograft (PDX) models. Mechanistically, 4-C-3 suppresses CRC tumorigenesis by dually targeting the epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homologue (KRAS). 4-C-3 directly binds to EGFR, blocking its signal transduction by inhibiting the binding of EGFR ligands. Additionally, 4-C-3 inhibits oncogenic KRAS variants, such as KRASG12D, by suppressing nucleotide exchange activity and effector engagement. By targeting both EGFR and KRAS, 4-C-3 reduces primary resistance to anti-EGFR therapies caused by KRAS mutations in CRC. As a proof-of-concept study, we showed that delivery of 4-C-3 by Oscillibacter ruminantium, a 4-C-3- producing commensal bacterium that is reduced in CRC patients, or a nonpathogenic Escherichia coli strain engineered to specifically convert intestinal cholesterol into 4-C-3, removed intratumoral cholesterol and led to rapid tumor regression in multiple models of CRC. These results suggest that microbial therapies for restoring intestinal cholesterol homeostasis represent a new therapeutic avenue for CRC.

cancer biology↗

Cell type-specific contributions to impaired blood-brain barrier and cerebral metabolism in presymptomatic 5XFAD mice

Altered cerebral metabolism and blood-brain barrier (BBB) dysfunction are emerging as critical contributors to the preclinical phase of Alzheimers disease (AD), underscoring their role in early pathogenesis. To identify sensitive biomarkers before irreversible neuronal loss and cognitive decline, we examined 5XFAD mice at 3 months of age by applying multiple advanced MRI techniques. Arterial spin tagging based MRI revealed increased BBB permeability and water extraction fraction, indicating compromised BBB integrity at the early stage of pathogenesis in 5xFAD mice. Despite preserved cerebral blood flow, a decreased unit mass cerebral metabolic rate of oxygen (CMRO2) was evident in the same cohorts of 5XFAD mice. Interestingly, a region-specific decrease of tissue pH values was detected in the hippocampus of these 5XFAD mice by creatine chemical exchange saturation transfer MRI. Elevated neuronal H4K12 lactylation in the hippocampus supports the reduced pH values. To further dissect the cellular and molecular mechanisms underlying these MRI-detectable changes in 5XFAD mice, we conducted single-nucleus RNA sequencing (snRNA-Seq) with optimized blood vessel enrichment protocols. Our results revealed cell type-specific transcriptomic changes in the hippocampus of 3-month-old 5XFAD mice, including downregulation of synaptogenesis and synaptic transmission genes in the CA1 and dentate gyrus excitatory neurons, impaired endothelial gene expression linked to brain barrier function and angiogenesis, altered innate immune response genes in astrocytes, as well as upregulation of cholesterol biosynthesis and metabolism genes in the CA1 excitatory neurons. These findings underlie the intricate interplay between BBB disruption and metabolic dysregulation before the onset of cognitive decline in AD. Our study demonstrates that BBB dysfunction and cerebral metabolic alterations preceded brain hypoperfusion and cognitive decline, emphasizing potential molecular pathways for early intervention. These findings, once validated in human studies, could significantly enhance early diagnosis and inform novel therapeutic strategies targeting early AD pathogenesis.

neuroscience↗

Global and cross-omics feature aggregation improves single-cell multi-omics integration and clustering

Sequencing technology advancements enable the simultaneous measurement of multiple omics within single cells, thereby facilitating single-cell multi-omics analysis. Most existing deep multi-omics integration methods learn shared or omics-specific representations from multiple omics by omics-wise aggregation. However, these approaches often fail to account for the structural relationships among all cells. Here, we introduce scCODI, an innovative cross-omics deep learning model to integrate single-cell multi-omics data for cell clustering. This model processes paired omics datasets, combining single-cell transcriptomics with either epigenomics or proteomics data to facilitate a more comprehensive exploration of cellular heterogeneity. Specifically, the shared representation of two omics is derived through cross-omics feature aggregation, fully leveraging the complementarity of different omics within the same cell. Additionally, we align the omic-specific and shared representations of each cell using a global relationship-guided contrastive learning module, which enhances the similarity between the shared and omic-specific representations of the same cell. Extensive experiments demonstrate that scCODI outperforms previous methods in single-cell multi-omics data integration and cell clustering, as evidenced by its performance across nine paired multi-omics datasets. This makes it a promising tool for decoding complex biological mechanisms. The code is available at https://github.com/SXUI-BDSI/scCODI

bioinformatics↗

Microsurgical Cervical Lymphaticovenous Anastomosis: A Novel Mouse Model for Brain Lymphatic Outflow

BackgroundCervical lymphaticovenous bypass has recently emerged as an innovative surgical approach to enhance brain lymphatic clearance for the treatment of Alzheimers disease (AD). While early clinical findings are promising, the absence of a reproducible preclinical model has hindered mechanistic investigations and translational advancements. ObjectiveThis study aimed to establish the first rat model for cervical LVA, addressing technical challenges and providing a standardized platform for preclinical research on lymphatic clearance and its role in neurodegeneration. MethodsRats underwent bilateral cervical LNVA using high-magnification supermicrosurgical techniques. Following identification of the deep cervical lymph nodes, end-to-side lymph node-to-venous anastomosis was performed. Anastomotic patency was confirmed intraoperatively by direct visualization without leakage. Indocyanine green (ICG) lymphangiography, performed via nasal administration, demonstrated fluorescence drainage into the external jugular vein. ResultsWith progressive refinement of microsurgical skills and improved anatomical familiarity, procedural stability was achieved. In the final cohort of five rats, all LVA procedures resulted in successful anastomotic patency. ConclusionThis study is the first to establish a rat model of cervical deep lymph node-venous anastomosis (LNVA), offering a novel microsurgical platform with dual value. On one hand, it serves as a technically demanding and reproducible model for advanced training in plastic and lymphatic surgery. On the other, it provides a structurally precise, gain-of-function approach for targeted intervention of the deep cervical lymph nodes--an anatomical hub increasingly implicated in brain lymphatic clearance and neurodegeneration. As such, this model may contribute meaningfully to future mechanistic studies on glymphatic function and its modulation.

animal behavior and cognition↗

Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington disease

Huntingtons disease (HD) is a progressive neurodegenerative disorder caused by a CAG-repeat expansion in exon-1 of the huntingtin gene. Currently, no disease-modifying therapies are available, with a significant challenge in evaluating therapeutic efficacy before clinical symptoms emerge. This highlights the need for early biomarkers and intervention strategies. Therefore, it is essential to develop and characterize accurate mouse models and identify early biomarkers for preclinical therapeutic development. In this study, we characterized the pathological progression of the heterozygous zQ175 neo-deleted knock in (zQ175DN) mouse model across four age groups: 3, 6, 10, and 16 months to identify human translatable outcome measures. T2-relaxation-under-spin-tagging (TRUST) MRI was used to assess global CMRO2, while T2-weighted MRI was used to analyze brain volumes. Significant brain volume loss was detected as early as 6 months of age, worsening progressively with age in the zQ175 DN mice, resembling HD brain volumetric changes. A decline in CMRO2 was observed in 6-month-old zQ175 DN mice, with significant and progressive reductions in 10- and 16-months old HD mice. Additionally, PHP1-positive mutant huntingtin (mHTT) aggregates were present in the striatum of zQ175 DN mice at all four age groups, with intranuclear localization prior to 6 months, transitioning to both intranuclear and neuropil aggregates in older zQ175 DN mice, suggesting that the localization of mHTT aggregates may reflect the severity of HD pathogenesis. Interestingly, plasma neurofilament light chain (NfL) protein concentrations were significantly elevated at 6 months of age and older zQ175DN mice. These findings provide valuable insights for selecting outcome measures in preclinical evaluations of HD therapies using the zQ175 DN mouse model.

neuroscience↗

Bidirectional crusher gradient method for estimating the labeling efficiency of pseudo-continuous arterial spin labeling MRI in mice

Pseudo-continuous arterial spin labeling (pCASL) MRI is a widely used imaging technique for studying brain perfusion in health and disease due to its non-invasive and non-contrast nature. Accurate quantification of absolute perfusion values from pCASL signals requires the knowledge of labeling efficiency. However, to date, a reliable technique to measure pCASL labeling efficiency has not been available. In this study, we propose a method using bidirectional crusher gradients to modulate vascular signals in the azygos pericallosal artery (azPA) of the mouse brain, applied with and without pCASL labeling. The combination of corresponding signals allows the estimation of labeling efficiency. Upon systematic testing, optimal acquisition parameters included a labeling duration [≥] 1170 ms, a repetition time of 3 seconds, and an imaging slice thickness of 0.75 mm. In order to quantitatively estimate labeling efficiency, the bolus arrival time to azPA is required and found to be 218.7 +/- 13.3 ms. Typical labeling efficiencies in mouse pCASL scans were 0.780 +/- 0.048 (mean +/- standard deviation). Furthermore, faster arterial flow induced by hypercapnia was found to increase pCASL labeling efficiency. Our method can improve the accuracy of pCASL quantification in mice, offering great potential for advancing its applications in pathophysiological studies.

neuroscience↗

Enzyme Co-Scientist: Harnessing Large Language Models for Enzyme Kinetic Data Extraction from Literature

The extraction of molecular annotations from scientific literature is critical for advancing data-driven research. However, traditional methods, which primarily rely on human curation, are labor-intensive and error-prone. Here, we present an LLM-based agentic workflow that enables automatic and efficient data extraction from literature with high accuracy. As a demonstration, our workflow successfully delivers a dataset containing over 91,000 enzyme kinetics entries from around 3,500 papers. It achieves an average F1 score above 0.9 on expert-annotated subsets of protein enzymes and can be extended to the ribozyme domain in fewer than 3 days at less than $90. This method opens up new avenues for accelerating the pace of scientific research.

biochemistry↗

TEMI: Tissue Expansion Mass Spectrometry Imaging

The spatial distribution of diverse biomolecules in multicellular organisms is essential for their physiological functions. High-throughput in situ mapping of biomolecules is crucial for both basic and medical research, and requires high scanning speed, spatial resolution, and chemical sensitivity. Here, we developed a Tissue Expansion method compatible with matrix-assisted laser desorption/ionization Mass spectrometry Imaging (TEMI). TEMI reaches single-cell spatial resolution without sacrificing voxel throughput and enables the profiling of hundreds of biomolecules, including lipids, metabolites, peptides (proteins), and N-glycans. Using TEMI, we mapped the spatial distribution of biomolecules across various mammalian tissues and uncovered metabolic heterogeneity in tumors. TEMI can be easily adapted and broadly applied in biological and medical research, to advance spatial multi-omics profiling.

molecular biology↗

SCOIGET: Predicting Spatial Tumor Evolution Pattern by Inferring Spatial Copy Number Variation Distributions

Constructing a comprehensive spatiotemporal map of tumor heterogeneity is essential for understanding tumor evolution, with copy number variation (CNV) as a significant feature. Existing studies often rely on tools originally developed for single-cell data, which fail to utilize spatial information. Our study aims to develop a model that fully leverages spatial omics data to elucidate spatio-temporal changes in tumor evolution. Here, we introduce SCOIGET (Spatial COpy number Inference by Graph on Evolution of Tumor), a novel framework using graph neural networks with graph attention layers to learn spatial neighborhood features of gene expression and infer copy number variations. This approach integrates spatial multi-omics features to create a comprehensive spatial map of tumor heterogeneity. Notably, SCOIGET achieves a substantial reduction in error metrics (e.g., mean squared error, cosine similarity, and distance measures) and produces superior clustering performance as indicated by higher Silhouette Scores compared to existing methods. Our model significantly enhances the efficiency and accuracy of tumor evolution depiction, capturing detailed spatial and temporal changes within the tumor microenvironment. It is versatile and applicable to various downstream tasks, demonstrating strong generalizability across different spatial omics technologies and cancer types. This robust performance improves research efficiency and provides valuable insights into tumor progression. In conclusion, SCOIGET offers an innovative solution by integrating multiple features and advanced algorithms, providing a detailed and accurate representation of tumor heterogeneity and evolution, aiding in the development of personalized cancer treatment strategies. Key PointsO_ST_ABS1. Innovative Framework for Spatially Contextualized CNV InferenceC_ST_ABSIntroduces SCOIGET, a graph-based model that integrates spatial omics data with graph neural networks and attention mechanisms to accurately infer spatial copy number features. 2. Detailed Tumor Heterogeneity MappingConstructs representations of tumor evolution, capturing heterogeneity and clonal dynamics at both cellular and subcellular resolutions. 3. Versatile and Robust PerformanceOutperforms existing methods across multiple datasets, demonstrating reliability and adaptability to diverse spatial omics platforms and cancer types. 4. Broad Downstream ApplicationsEnables tasks such as tumor subclone identification, clustering, and evolutionary trajectory analysis, facilitating precision oncology strategies.

bioinformatics↗

Repetitive magnetic stimulation with iTBS600 induces persistent structural and functional plasticity in mouse organotypic slice cultures

BackgroundRepetitive transcranial magnetic stimulation (rTMS) is well known for its ability to induce synaptic plasticity, yet its impact on structural and functional remodeling within stimulated networks remains unclear. This study investigates the cellular and network-level mechanisms of rTMS-induced plasticity using a clinically approved 600-pulse intermittent theta burst stimulation (iTBS600) protocol applied to organotypic brain tissue cultures. MethodsWe applied iTBS600 to entorhino-hippocampal organotypic tissue cultures and conducted a 24-hour analysis using c-Fos immunostaining, whole-cell patch-clamp recordings, time-lapse imaging of dendritic spines, and calcium imaging. ResultsWe observed long-term potentiation (LTP) of excitatory synapses in dentate granule cells, characterized by increased mEPSC frequencies and spine remodeling over time. c-Fos expression in the dentate gyrus was transient and exhibited a clear sensitivity to the orientation of the induced electric field, suggesting a direction-dependent induction of plasticity. Structural remodeling of dendritic spines was temporally linked to enhanced synaptic strength, while spontaneous firing rates remained stable during the early phase in the dentate gyrus, indicating the engagement of homeostatic mechanisms. Despite the widespread electric field generated by rTMS, its effects were spatially and temporally precise, driving Hebbian plasticity and region-specific spine dynamics. ConclusionsThese findings provide mechanistic insights into how rTMS-induced LTP promotes targeted plasticity while preserving network stability. Understanding these interactions may help refine stimulation protocols to optimize therapeutic outcomes.

neuroscience↗

Decoding yeast transcriptional regulation via a data- and mechanism-driven distributed large-scale network model

The complex transcriptional regulatory relationships among genes influence gene expression levels and play crucial roles in determining cellular phenotypes. Here, we present a novel distributed large-scale transcriptional regulatory neural network model (DLTRNM) by integrating prior knowledge into the reconstruction of pre-trained machine learning models followed with fine-tuning. Taken S. cerevisiae as the example, the transcriptional regulatory relationships, carefully compiled and documented, are utilized to define interactions between TFs and their TGs within DLTRNM. Subsequently, DLTRNM is pre-trained on pan-transcriptomic data and fine-tuned with time-series data, enabling it to accurately predict dynamic regulatory correlations between TFs and TGs, such as simulating TG responses by tuning the expression of TFs. In addition, DLTRNM can assist in identifying potential key TFs for a subset of genes, thus simplifying the complex and interrelated transcriptional regulatory networks (TRN). Based on the key TFs, it can also refine previously reported transcriptional regulatory subnetworks and highlight the core regulatory networks. DLTRNM offers a powerful tool for studying transcriptional regulation with reduced computational demands and enhanced interpretability. Thus, this study represents a significant step forward in systems biology for understanding the complicated transcriptional regulation within cells.

bioinformatics↗

A cell type-specific mechanism driving the rapid antidepressant effects of transcranial magnetic stimulation

Repetitive transcranial magnetic stimulation (rTMS) is an emerging treatment for brain disorders, but its therapeutic mechanism is unknown. We developed a novel mouse model of rTMS with superior clinical face validity and investigated the neural mechanism by which accelerated intermittent theta burst stimulation (aiTBS) - the first rapid-acting rTMS antidepressant protocol - reversed chronic stress-induced behavioral deficits. Using fiber photometry, we showed that aiTBS drives distinct patterns of neural activity in intratelencephalic (IT) and pyramidal tract (PT) projecting neurons in dorsomedial prefrontal cortex (dmPFC). However, only IT neurons exhibited persistently increased activity during both aiTBS and subsequent depression-related behaviors. Similarly, aiTBS reversed stress-related loss of dendritic spines on IT, but not PT neurons, further demonstrating cell type-specific effects of stimulation. Finally, chemogenetic inhibition of dmPFC IT neurons during rTMS blocked the antidepressant-like behavioral effects of aiTBS. Thus, we demonstrate a prefrontal mechanism linking rapid aiTBS-driven therapeutic effects to cell type-specific circuit plasticity.

neuroscience↗

Transferring functional chromosomes between intergeneric yeast generates monochromosomal hybrids with improved phenotypes and transcriptional responses

Interspecific genetic exchanges caused by natural hybridization or horizontal gene transfer can lead to enhanced phenotypes, which are often of interest for industrial applications and evolutionary research. However, transferring genetic materials between distantly related species, such as intergeneric yeasts, presents technical challenges. In this study, we established a method to transfer individual chromosomes from Saccharomyces cerevisiae (Sc) into Kluyveromyces marxianus (Km), an emerging model for bioproduction. The Sc chromosome of interest was circularized, genetically modified to carry Km centromeres and replication origins, and transformed into Km via protoplast transformation. Using this method, we generated two synthetic strains, each containing a full set of Km chromosomes and either Sc chromosome I or III. The Sc chromosomes exhibited normal replication, segregation, and active transcription after the transfer. The synthetic strains displayed enhanced phenotypes in flocculation and salt tolerance, which were found to be caused by transgressive expression of FLO9 and SPS22 on the transferred Sc chromosomes, respectively. Transcriptomic analysis revealed that transgressive expression was prevalent among the transferred Sc genes, suggesting evolution of lineage-specific cis- and trans-regulatory interactions across a long evolutionary timescale. Our strategy has potential applications in optimizing cell factories, constructing synthetic genomes, and advancing evolutionary research.

synthetic biology↗

Resolving inconsistent effects of tDCS on learning using a homeostatic structural plasticity model

Transcranial direct current stimulation (tDCS) is increasingly used to modulate motor learning. Current polarity and intensity, electrode montage, and application before or during learning had mixed effects. Both Hebbian and homeostatic plasticity were proposed to account for the observed effects, but the explanatory power of these models is limited. In a previous modeling study, we showed that homeostatic structural plasticity (HSP) can explain long-lasting after-effects of tDCS and transcranial magnetic stimulation (TMS). The interference between motor learning and tDCS, which are both based on HSP in our model, is a candidate mechanism to resolve complex and seemingly contradictory experimental observations. We implemented motor learning and tDCS in a spiking neural network subject to HSP. The anatomical connectivity of the engram induced by motor learning was used to quantify the impact of tDCS on motor learning. Our modeling results demonstrated that transcranial direct current stimulation applied before learning had weak modulatory effects. It led to a small reduction in connectivity if it was applied uniformly. When applied during learning, targeted anodal stimulation significantly strengthened the engram, while targeted cathodal or uniform stimulation weakened it. Applied after learning, targeted cathodal, but not anodal, tDCS boosted engram connectivity. Strong tDCS would distort the engram structure if not applied in a targeted manner. Our model explained both Hebbian and homeostatic phenomena observed in human tDCS experiments by assuming memory strength positively correlates with engram connectivity. This includes applications with different polarity, intensity, electrode montage, and timing relative to motor learning. The HSP model provides a promising framework for unraveling the dynamic interaction between learning and transcranial DC stimulation.

neuroscience↗

BicD and MAP7 collaborate to activate homodimeric Drosophila kinesin-1 by complementary mechanisms

The folded auto-inhibited state of kinesin-1 is stabilized by multiple weak interactions and binds weakly to microtubules. Here we investigate the extent to which homodimeric Drosophila kinesin-1 lacking light chains is activated by the dynein activating adaptor Drosophila BicD. We show that one or two kinesins can bind to the central region of BicD (CC2), a region distinct from that which binds dynein-dynactin (CC1) and cargo-adaptor proteins (CC3). Kinesin light chain significantly reduces the amount of kinesin bound to BicD and thus regulates this interaction. Binding of kinesin to BicD increases the number of motors bound to the microtubule, the fraction moving processively and the run length, suggesting that BicD relieves kinesin auto-inhibition. In contrast, microtubule-associated protein 7 (MAP7) has minimal impact on the percentage of motors moving processively but enhances both kinesin-1 recruitment to microtubules and run length. BicD relieves auto-inhibition of kinesin, while MAP7 enables activated motors to engage productively with microtubules. When BicD and MAP7 are combined, the most robust activation of kinesin-1 occurs, highlighting the crosstalk between adaptors and microtubule associated proteins in regulating transport. These observations imply that when both dynein and kinesin-1 are simultaneously bound to BicD, the direction the complex moves on MTs will be influenced by MAP7 and the number of bound kinesins.

biophysics↗

Peripheral alcohol metabolism dictates ethanol consumption and drinking microstructure in mice

BackgroundEthanol metabolism is intimately linked with the physiological and behavioral aspects of ethanol consumption. Ethanol is mainly oxidized by alcohol dehydrogenase (ADH) to acetaldehyde and further to acetate via aldehyde dehydrogenases (ALDHs). Understanding how ethanol and its metabolites work together to initiate and drive continued ethanol consumption is crucial for identifying interventions for alcohol use disorder (AUD). Therefore, the goal of our study was to determine how ADH1, which is mainly peripherally-expressed and metabolizes >90% of ingested ethanol, modulates ethanol metabolite distribution and downstream behaviors. MethodsEthanol consumption in drinking-in-the-dark (DID) and two-bottle choice (2BC) drinking paradigms, ethanol metabolite concentrations, and lickometry were assessed after ADH1 inhibition and/or in Adh1-knockout (Adh1 KO) mice. ResultsWe found that Adh1 KO mice of both sexes exhibited decreased ethanol consumption and preference compared to wild-type (WT) mice in DID and 2BC. ADH1 inhibitor fomepizole (4-MP) also significantly decreased normal and sweetened ethanol consumption in DID studies. Measurement of ethanol and its metabolites revealed that ethanol was increased at 1h but not 15 min, peripheral acetaldehyde was slightly decreased at both time points, and ethanol-induced increases in acetate were abolished after ethanol administration in Adh1 KO mice compared to controls. Similarly, ethanol accumulation as a function of consumption was 2-fold higher in Adh1 KO or 4-MP treated mice compared to controls. We then used lickometry to determine how this perturbation in ethanol metabolism affects drinking microstructure. Adh1 KO mice consume most of their ethanol in the first 30 min like WT mice but display altered temporal shifts in drinking behaviors and do not form normal bout structures, resulting in lower ethanol consumption. ConclusionsOur study demonstrates that ADH1-mediated ethanol metabolism is a key determinant of ethanol consumption, highlighting a fundamental knowledge gap around how ethanol and its metabolites drive ethanol consumption.

neuroscience↗